Citadel Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

Citadel Advisors’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-188	Closed	-$15K	–	8266
2015 Q4	$15K	Sell	188 -71	-27%	-$35K	﹤0.01%	8125
2015 Q3	$174K	Buy	259 +190	+275%	+$135K	﹤0.01%	6325
2015 Q2	$46K	Buy	69 +65	+1,625%	+$43K	﹤0.01%	7707
2015 Q1	$3K	Hold	4	–	–	﹤0.01%	8394
2014 Q4	$2K	Sell	4 -28	-88%	-$14K	﹤0.01%	8383
2014 Q3	$19K	Buy	32 +27	+540%	+$18.7K	﹤0.01%	7494
2014 Q2	$4K	Sell	5 -1	-17%	-$663	﹤0.01%	7772
2014 Q1	$5K	Sell	6 -15	-71%	-$12.2K	﹤0.01%	7657
2013 Q4	$16K	Buy	+21	New	+$15.8K	﹤0.01%	6577
2013 Q3	–	Sell	-28	Closed	-$24K	–	6918
2013 Q2	$24K	Buy	+28	New	+$23.7K	﹤0.01%	5996

Other funds holding MTEM

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Citadel Advisors's MTEM Position: Q3 2022 in Review

Citadel Advisors sold out of Molecular Templates, Inc. (MTEM) in Q3 2022, closing a stake of 8,362 shares — an estimated $114K sold.

Citadel Advisors first reported a position in MTEM in Q2 2013 and held it in 23 quarters. The position peaked at $701K in Q3 2015. 58 funds tracked by Wall St. Rank hold MTEM as of Q3 2022.

Citadel Advisors reported no remaining Molecular Templates, Inc. position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 8,362 Molecular Templates, Inc. shares in Q3 2022, an estimated $114K.
Citadel Advisors first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 23 quarters.
Citadel Advisors's Molecular Templates, Inc. position peaked at $701K in Q3 2015.
58 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.